Neuroprotective Effect of Palmitoylethanolamide in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy

Authors:

Abstract
Epilepsy is one of the most common chronic neurological diseases. About 30% of patients with epilepsy suffer from drug resistant forms of the disease. In this regard, a thorough investigation of the pathogenetic mechanisms of epilepsy, as well as a search for new anticonvulsant or neuroprotective compounds, are still relevant. Evaluation of the effects of endogenous compounds in experimental models of epilepsy can be useful for solving both of these problems. The aim of this study was to assess the neuroprotective effect of palmitoylethanolamide (PEA) in a lithium-pilocarpine model of temporal lobe epilepsy in Wistar rats at the age of 10–11 weeks. PEA was applied subcutaneously at a dose of 10 mg/kg one hour after the relief of status epilepticus (SE) and then at a daily basis for 7 days. The neuroprotective properties of PEA were assessed by changes in behavior in the open field test before SE and 20 days thereafter, as well as by changes in the neuronal density in the CA1 region and hilus of the dorsal and ventral hippocampus, and the degree of mossy fiber retrograde sprouting into the molecular layer of the dentate gyrus 21 days after SE. It was found that PEA administration during the first week after SE leads to a retention of some behavioral features of healthy animals, reduces the degree of neurodestruction in CA1 and the level of mossy fiber retrograde sprouting in both the dorsal and ventral hippocampus. Thus, the results of the study indicate a moderate neuroprotective effect of PEA in the model of temporal lobe epilepsy.

This publication has 39 references indexed in Scilit: